This inventor holds 1 USPTO granted patent. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Manfred Hunz: Innovator in Pharmaceutical Chemistry
Introduction
Manfred Hunz is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various medical disorders. His work has led to the creation of innovative treatments that have the potential to improve patient outcomes.
Latest Patents
Hunz holds a patent for "Substituted phenols and their use for the treatment of disorders caused by cell proliferation." This patent describes substituted phenols of a specific formula and outlines processes for their preparation. The compositions containing these substituted phenols are aimed at treating disorders such as psoriasis, tumor disorders, and immunological disorders. His innovative approach in this area highlights the importance of chemical compounds in modern medicine.
Career Highlights
Throughout his career, Manfred Hunz has been associated with Behringwerke Aktiengesellschaft, a company known for its contributions to biopharmaceuticals. His work at this organization has allowed him to collaborate with other experts in the field and to further his research in pharmaceutical applications.
Collaborations
Hunz has worked alongside notable colleagues, including Jorg Czech and Hans-Harald Sedlacek. These collaborations have enriched his research and contributed to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Manfred Hunz's contributions to the field of pharmaceutical chemistry, particularly through his patented innovations, demonstrate his commitment to improving medical treatments. His work continues to influence the development of therapies for complex disorders, showcasing the vital role of inventors in healthcare advancements.